<DOC>
	<DOC>NCT00668109</DOC>
	<brief_summary>Assessment of efficacy of vardenafil in subjects with erectile dysfunction and diabetes, hypertension or hyperlipidemia</brief_summary>
	<brief_title>Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Age: 18 years and older Males with erectile dysfunction Stable heterosexual relationship Medical history / diagnosis of diabetes mellitus and/or hypertension and/or hyperlipidemia Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within the prior 6 months Nitrate use Other exclusion criteria apply according to Summary of Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Vardenafil</keyword>
</DOC>